期刊
JOURNAL OF CLINICAL ONCOLOGY
卷 29, 期 10, 页码 1382-1391出版社
AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2010.28.2319
关键词
-
类别
资金
- The European Fine Art Foundation
- Center for Translational Molecular Medicine [03O-101]
- Zorg Onderzoek Nederland Medische Wetenschappen [6120.0022]
Colorectal cancer (CRC) has predominantly been considered a genetic disease, characterized by sequential accumulation of genetic alterations. Growing evidence indicates that epigenetic alterations add an additional layer of complexity to the pathogenesis of CRC, and characterize a subgroup of colorectal cancers with a distinct etiology and prognosis. Epigenetic dysregulation in colorectal cancer is organized at multiple levels, involving DNA methylation, histone modifications, nucleosomal occupancy and remodeling, chromatin looping, and noncoding RNAs. Interactions between these processes and complex associations with genetic alterations have recently been unraveled. It appears that CRC epigenetics will be the paradigm for multistep carcinogenesis, as CRC genetics has been for the past three decades. This review integrates recent data on epigenetic regulation of gene expression in CRC and describes how the understanding of these processes will alter the management of CRC. J Clin Oncol 29: 1382-1391. (C) 2011 by American Society of Clinical Oncology
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据